Alvaro Herrera Pérez/LinkedIn
Jun 13, 2026, 16:21
Alvaro Herrera Pérez: Connecting Science and Care at EHA 2026
Alvaro Herrera Pérez, European MSL Lead at Agios Pharmaceuticals, shared a post on LinkedIn:
”Attending EHA 2026 at Stockholm.
Different country, same mission: collaborating with colleagues across Europe and the United States (Clinical Development and Medical Affairs) united by a common purpose: Improving outcomes for patients.
Scientific exchange, innovation, and teamwork continue to drive us forward, always with the patient at the center of everything we do.”
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge